ArticleCardiology2022

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.

Robert Krysiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.